Sign in
LITS Stock Price, Chart, Stats & News
Lite Strategy, Inc.
Save
Lite Strategy, Inc. (LITS) does not currently pay a dividend.
34.97M
Market cap
–
Current P/E
4.62x
Forward P/E
LITS chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -47.87% |
ROE | -68.86% |
D/E | – |
Interest coverage ratio | – |
LITS valuation
P/E | – |
P/S | – |
P/B | 0.09x |
P/CF | -0.60x |
P/FCF | -3.32x |
P/OCF | -0.60x |
PEG | 0.00x |
EV multiple | -3.89x |
About
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Similar securities
Based on sector and market capitalization
Report issue